• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effect of haematological improvement on survival in patients given targeted therapy as initial treatment of acute myeloid leukaemia or high-risk myelodysplastic syndrome.

作者信息

Yanada Masamitsu, Huang Xuelin, Garcia-Manero Guillermo, O'brien Susan, Ravandi Farhad, Borthakur Gautam, Faderl Stefan, Issa Jean-Pierre, Kantarjian Hagop, Estey Elihu

出版信息

Br J Haematol. 2007 Aug;138(4):555-7. doi: 10.1111/j.1365-2141.2007.06670.x. Epub 2007 Jun 25.

DOI:10.1111/j.1365-2141.2007.06670.x
PMID:17593249
Abstract
摘要

相似文献

1
Effect of haematological improvement on survival in patients given targeted therapy as initial treatment of acute myeloid leukaemia or high-risk myelodysplastic syndrome.血液学改善对接受靶向治疗作为急性髓系白血病或高危骨髓增生异常综合征初始治疗患者生存的影响。
Br J Haematol. 2007 Aug;138(4):555-7. doi: 10.1111/j.1365-2141.2007.06670.x. Epub 2007 Jun 25.
2
Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy.急性髓性白血病或高危骨髓增生异常综合征患者诱导化疗后达到细胞遗传学缓解的预后相关性。
Leuk Res. 2009 Sep;33(9):1189-93. doi: 10.1016/j.leukres.2009.03.004. Epub 2009 May 9.
3
Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias.骨髓增生异常综合征和急性髓系白血病的分子靶向治疗
Ann Hematol. 2006 Mar;85(3):139-63. doi: 10.1007/s00277-005-0051-7. Epub 2006 Jan 4.
4
Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Haematologica. 2006 Mar;91(3):373-6.
5
Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia.在急性髓系白血病和高危骨髓增生异常综合征的低强度预处理干细胞移植中，50毫克与100毫克阿仑单抗治疗后的疗效。
Br J Haematol. 2008 Jun;142(2):318-20. doi: 10.1111/j.1365-2141.2008.07184.x. Epub 2008 May 19.
6
[Acute myelogenous leukemia and myelodysplastic syndrome after treatment with cytostatic agents].[细胞毒性药物治疗后发生的急性髓系白血病和骨髓增生异常综合征]
Tidsskr Nor Laegeforen. 2000 Sep 10;120(21):2542-5.
7
A limited number of 5-azacitidine cycles can be effective treatment in MDS.有限数量的5-氮杂胞苷疗程可作为骨髓增生异常综合征的有效治疗方法。
Ann Hematol. 2009 Mar;88(3):213-9. doi: 10.1007/s00277-008-0583-8. Epub 2008 Aug 12.
8
Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.5-氮杂胞苷与沙利度胺联合治疗骨髓增生异常综合征和急性髓系白血病
Cancer. 2008 Oct 1;113(7):1596-604. doi: 10.1002/cncr.23789.
9
Response in acute myeloid leukemia.
Clin Adv Hematol Oncol. 2008 Feb;6(2):113-7.
10
Clofibric acid: a potential therapeutic agent in AML and MDS.
Br J Haematol. 1999 May;105(2):448-51.

引用本文的文献

1
Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study.完全缓解和不完全缓解对急性髓细胞白血病生存的影响：东部合作肿瘤学组、西南肿瘤学组和 M.D.安德森癌症中心的联合研究。
J Clin Oncol. 2010 Apr 1;28(10):1766-71. doi: 10.1200/JCO.2009.25.1066. Epub 2010 Feb 16.